Global Gene-based Advanced Therapy Medical Product Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Viral Gene Delivery System
  • 1.2.3 Non-viral Gene Delivery System
• 1.3 Market by Application
  • 1.3.1 Global Gene-based Advanced Therapy Medical Product Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Neurological Diseases
  • 1.3.3 Cancer
  • 1.3.4 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Gene-based Advanced Therapy Medical Product Market Perspective (2016-2027)
• 2.2 Gene-based Advanced Therapy Medical Product Growth Trends by Regions
  • 2.2.1 Gene-based Advanced Therapy Medical Product Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Gene-based Advanced Therapy Medical Product Historic Market Share by Regions (2016-2021)
  • 2.2.3 Gene-based Advanced Therapy Medical Product Forecasted Market Size by Regions (2022-2027)
• 2.3 Gene-based Advanced Therapy Medical Product Industry Dynamic
  • 2.3.1 Gene-based Advanced Therapy Medical Product Market Trends
  • 2.3.2 Gene-based Advanced Therapy Medical Product Market Drivers
  • 2.3.3 Gene-based Advanced Therapy Medical Product Market Challenges
  • 2.3.4 Gene-based Advanced Therapy Medical Product Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Gene-based Advanced Therapy Medical Product Players by Revenue
  • 3.1.1 Global Top Gene-based Advanced Therapy Medical Product Players by Revenue (2016-2021)
  • 3.1.2 Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Players (2016-2021)
• 3.2 Global Gene-based Advanced Therapy Medical Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Gene-based Advanced Therapy Medical Product Revenue
• 3.4 Global Gene-based Advanced Therapy Medical Product Market Concentration Ratio
  • 3.4.1 Global Gene-based Advanced Therapy Medical Product Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Gene-based Advanced Therapy Medical Product Revenue in 2020
• 3.5 Gene-based Advanced Therapy Medical Product Key Players Head office and Area Served
• 3.6 Key Players Gene-based Advanced Therapy Medical Product Product Solution and Service
• 3.7 Date of Enter into Gene-based Advanced Therapy Medical Product Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Gene-based Advanced Therapy Medical Product Breakdown Data by Type

• 4.1 Global Gene-based Advanced Therapy Medical Product Historic Market Size by Type (2016-2021)
• 4.2 Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Type (2022-2027)

5 Gene-based Advanced Therapy Medical Product Breakdown Data by Application

• 5.1 Global Gene-based Advanced Therapy Medical Product Historic Market Size by Application (2016-2021)
• 5.2 Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Gene-based Advanced Therapy Medical Product Market Size (2016-2027)
• 6.2 North America Gene-based Advanced Therapy Medical Product Market Size by Type
  • 6.2.1 North America Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2021)
  • 6.2.2 North America Gene-based Advanced Therapy Medical Product Market Size by Type (2022-2027)
  • 6.2.3 North America Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2027)
• 6.3 North America Gene-based Advanced Therapy Medical Product Market Size by Application
  • 6.3.1 North America Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2021)
  • 6.3.2 North America Gene-based Advanced Therapy Medical Product Market Size by Application (2022-2027)
  • 6.3.3 North America Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2027)
• 6.4 North America Gene-based Advanced Therapy Medical Product Market Size by Country
  • 6.4.1 North America Gene-based Advanced Therapy Medical Product Market Size by Country (2016-2021)
  • 6.4.2 North America Gene-based Advanced Therapy Medical Product Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Gene-based Advanced Therapy Medical Product Market Size (2016-2027)
• 7.2 Europe Gene-based Advanced Therapy Medical Product Market Size by Type
  • 7.2.1 Europe Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2021)
  • 7.2.2 Europe Gene-based Advanced Therapy Medical Product Market Size by Type (2022-2027)
  • 7.2.3 Europe Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2027)
• 7.3 Europe Gene-based Advanced Therapy Medical Product Market Size by Application
  • 7.3.1 Europe Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2021)
  • 7.3.2 Europe Gene-based Advanced Therapy Medical Product Market Size by Application (2022-2027)
  • 7.3.3 Europe Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2027)
• 7.4 Europe Gene-based Advanced Therapy Medical Product Market Size by Country
  • 7.4.1 Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2016-2021)
  • 7.4.2 Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size (2016-2027)
• 8.2 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Type
  • 8.2.1 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Application
  • 8.3.1 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region
  • 8.4.1 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Gene-based Advanced Therapy Medical Product Market Size (2016-2027)
• 9.2 Latin America Gene-based Advanced Therapy Medical Product Market Size by Type
  • 9.2.1 Latin America Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2021)
  • 9.2.2 Latin America Gene-based Advanced Therapy Medical Product Market Size by Type (2022-2027)
  • 9.2.3 Latin America Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2027)
• 9.3 Latin America Gene-based Advanced Therapy Medical Product Market Size by Application
  • 9.3.1 Latin America Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2021)
  • 9.3.2 Latin America Gene-based Advanced Therapy Medical Product Market Size by Application (2022-2027)
  • 9.3.3 Latin America Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2027)
• 9.4 Latin America Gene-based Advanced Therapy Medical Product Market Size by Country
  • 9.4.1 Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2016-2021)
  • 9.4.2 Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size (2016-2027)
• 10.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Type
  • 10.2.1 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Application
  • 10.3.1 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country
  • 10.4.1 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Biogen
  • 11.1.1 Biogen Company Details
  • 11.1.2 Biogen Business Overview
  • 11.1.3 Biogen Gene-based Advanced Therapy Medical Product Introduction
  • 11.1.4 Biogen Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.1.5 Biogen Recent Development
• 11.2 Novartis
  • 11.2.1 Novartis Company Details
  • 11.2.2 Novartis Business Overview
  • 11.2.3 Novartis Gene-based Advanced Therapy Medical Product Introduction
  • 11.2.4 Novartis Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.2.5 Novartis Recent Development
• 11.3 Gilead Sciences
  • 11.3.1 Gilead Sciences Company Details
  • 11.3.2 Gilead Sciences Business Overview
  • 11.3.3 Gilead Sciences Gene-based Advanced Therapy Medical Product Introduction
  • 11.3.4 Gilead Sciences Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.3.5 Gilead Sciences Recent Development
• 11.4 Sarepta Therapeutics
  • 11.4.1 Sarepta Therapeutics Company Details
  • 11.4.2 Sarepta Therapeutics Business Overview
  • 11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Introduction
  • 11.4.4 Sarepta Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.4.5 Sarepta Therapeutics Recent Development
• 11.5 Alnylam Pharmaceuticals
  • 11.5.1 Alnylam Pharmaceuticals Company Details
  • 11.5.2 Alnylam Pharmaceuticals Business Overview
  • 11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Introduction
  • 11.5.4 Alnylam Pharmaceuticals Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.5.5 Alnylam Pharmaceuticals Recent Development
• 11.6 Amgen
  • 11.6.1 Amgen Company Details
  • 11.6.2 Amgen Business Overview
  • 11.6.3 Amgen Gene-based Advanced Therapy Medical Product Introduction
  • 11.6.4 Amgen Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.6.5 Amgen Recent Development
• 11.7 Spark Therapeutics
  • 11.7.1 Spark Therapeutics Company Details
  • 11.7.2 Spark Therapeutics Business Overview
  • 11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medical Product Introduction
  • 11.7.4 Spark Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.7.5 Spark Therapeutics Recent Development
• 11.8 Akcea Therapeutics
  • 11.8.1 Akcea Therapeutics Company Details
  • 11.8.2 Akcea Therapeutics Business Overview
  • 11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Introduction
  • 11.8.4 Akcea Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.8.5 Akcea Therapeutics Recent Development
• 11.9 bluebird bio
  • 11.9.1 bluebird bio Company Details
  • 11.9.2 bluebird bio Business Overview
  • 11.9.3 bluebird bio Gene-based Advanced Therapy Medical Product Introduction
  • 11.9.4 bluebird bio Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.9.5 bluebird bio Recent Development
• 11.10 Sunway Biotech
  • 11.10.1 Sunway Biotech Company Details
  • 11.10.2 Sunway Biotech Business Overview
  • 11.10.3 Sunway Biotech Gene-based Advanced Therapy Medical Product Introduction
  • 11.10.4 Sunway Biotech Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.10.5 Sunway Biotech Recent Development
• 11.11 SIBIONO
  • 11.11.1 SIBIONO Company Details
  • 11.11.2 SIBIONO Business Overview
  • 11.11.3 SIBIONO Gene-based Advanced Therapy Medical Product Introduction
  • 11.11.4 SIBIONO Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.11.5 SIBIONO Recent Development
• 11.12 AnGes
  • 11.12.1 AnGes Company Details
  • 11.12.2 AnGes Business Overview
  • 11.12.3 AnGes Gene-based Advanced Therapy Medical Product Introduction
  • 11.12.4 AnGes Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.12.5 AnGes Recent Development
• 11.13 Orchard Therapeutics
  • 11.13.1 Orchard Therapeutics Company Details
  • 11.13.2 Orchard Therapeutics Business Overview
  • 11.13.3 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Introduction
  • 11.13.4 Orchard Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.13.5 Orchard Therapeutics Recent Development
• 11.14 Human Stem Cells Institute
  • 11.14.1 Human Stem Cells Institute Company Details
  • 11.14.2 Human Stem Cells Institute Business Overview
  • 11.14.3 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Introduction
  • 11.14.4 Human Stem Cells Institute Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
  • 11.14.5 Human Stem Cells Institute Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer